...
首页> 外文期刊>Molecular medicine reports >Genetic counseling for patients with nonsyndromic hearing impairment directed by gene analysis
【24h】

Genetic counseling for patients with nonsyndromic hearing impairment directed by gene analysis

机译:基因分析指导非综合征性听力障碍患者的遗传咨询

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of the present study was to investigate the genetic etiology of patients with nonsyndromic hearing impairment through gene analysis, and provide accurate genetic counseling and prenatal diagnosis for deaf patients and families with deaf children. Previous molecular etiological studies have demonstrated that the most common molecular changes in Chinese patients with nonsyndromic hearing loss (NSHL) involved gap junction protein 2, solute carrier family 26, member 4 (SLC26A4), and mitochondrial DNA 12S rRNA. A total of 117 unrelated NSHL patients were included. Mutation screening was performed by Sanger sequencing in GJB2, 12S rRNA, and the hot-spot regions of SLC26A4. In addition, patients with a single mutation of SLC26A4 in the hot-spot regions underwent complete exon sequencing to identify a mutation in the other allele. A total of 36 of the 117 deaf patients were confirmed to have two pathogenic mutations, which included 4 deaf couples, husband or wife in 11 deaf couples and 17 deaf individuals. In addition, prenatal diagnoses was performed in 7 pregnant women at 18-21 weeks gestation who had previously given birth to a deaf child, and the results showed that two fetal genotypes were the same as the proband's genotypes, four fetuses carried one pathogenic gene from their parents, and one fetus was identified to have no mutations. Taken together, the genetic testing of deaf patients can provide reasonable guidance to deaf patients and families with deaf children.
机译:本研究的目的是通过基因分析研究非综合征性听力障碍患者的遗传病因,并为聋人患者和聋儿家庭提供准确的遗传咨询和产前诊断。先前的分子病因学研究表明,在中国非综合征性听力损失(NSHL)患者中,最常见的分子变化涉及间隙连接蛋白2,溶质载体家族26,成员4(SLC26A4)和线粒体DNA 12S rRNA。总共包括117名无关的NSHL患者。通过Sanger测序在GJB2、12S rRNA和SLC26A4的热点区域进行突变筛选。另外,在热点区域中具有SLC26A4单一突变的患者接受了完整的外显子测序,以鉴定其他等位基因中的突变。 117名聋哑患者中总共有36名被确认具有两个致病突变,包括4名聋哑夫妇,11名聋哑夫妇中的丈夫或妻子和17名聋哑人。另外,对7名在18-21周妊娠的孕妇进行了产前诊断,这些孕妇以前曾生过一个聋子,结果表明两种胎儿基因型与先证者的基因型相同,其中四名胎儿携带了一个致病基因。他们的父母和一名胎儿被确认没有突变。综上所述,聋人的基因检测可以为聋人和聋儿家庭提供合理的指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号